CRE-Luc GPCR Reporter Mouse, Line 64

Random Transgenic

Cryopreserved CRE-Luc GPCR Reporter Mouse, Line 64 - Taconic Biosciences
This line is cryopreserved and requires cryorecovery.

FVB Background

  • Model #
  • Genotype
  • Nomenclature
  • 11518-F
  • 11518-M
  • Expresses luciferase under the control of the cAMP response element (CRE)
  • GPCR signaling through the cAMP pathway can be detected from the target GPCR that is in a native cellular environment with a full compliment of associated receptors and membrane constituents
  • Luciferase is expressed primarily in the spleen and kidney in Line 64
  • Useful for screening in vivo, ex vivo, and in vitro using whole animals, tissues and primary cells
  • Learn more about the CRE-Luc GPCR Reporter Mouse Platform
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.

Genetic Background:

FVB Background


The CRE-Luc GPCR Reporter Mouse, Line 64 was developed by Sanofi. The model was created by microinjecting a transgene containing a 6x CRE promoter, the HSV TK minimal promoter, modified firefly luciferase cDNA from pGL4 and a human growth hormone polyA tail. This transgene was microinjected into FVB/NTac zygotes. The resultant mice from founder line 64 were bred to FVB/NTac mice. Taconic received stock from Sanofi in 2012. The line was embryo transfer derived. In the production colony, the line is maintained by mating homozygous males and females.





Initial Publication:

This line is available for immediate cryorecovery. A limited breeding agreement with a license fee is required. Cryorecovery fees are additional.